CompletedNot Applicable

Prognostic Value of PLR On Cardiovascular Complications in Chronic Hemodialysis Patients

Egypt80 participantsStarted 2024-01-04

Plain-language summary

Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients undergoing hemodialysis for more than 3 months who agreed to be included in the study Exclusion Criteria: * We are going to exclude patients who have: * Younger than 18 year- old or Older than 75 year-old, * Patients with positive serum marker of anti-hepatitis C virus (anti-HCV), hepatitis B surface antigen (HBsAg) and human immunodeficiency virus (HIV). * Alcohol or illicit drug abusers. * Inflammatory state due to infection,

What they're measuring

To evaluate the association between platelet-to-lymphocyte ratio and cardiovascular complications in patients on chronic maintenance hemodialysis.

Timeframe: 6 months

Trial details

NCT IDNCT07519785

SponsorMinia University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-04

View on ClinicalTrials.gov More Cardiovascular Complications in Hemodialysis trials